Bionano Genomics (NASDAQ:BNGO) Sets New 12-Month Low – Here’s What Happened

Bionano Genomics, Inc. (NASDAQ:BNGOGet Free Report)’s stock price hit a new 52-week low on Monday . The stock traded as low as $6.04 and last traded at $6.02, with a volume of 160997 shares. The stock had previously closed at $7.29.

Wall Street Analyst Weigh In

Separately, LADENBURG THALM/SH SH downgraded shares of Bionano Genomics from a “buy” rating to a “neutral” rating in a research report on Friday, November 15th.

Check Out Our Latest Analysis on Bionano Genomics

Bionano Genomics Stock Performance

The company has a market cap of $679.89 million, a PE ratio of -2.55 and a beta of 2.22. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.99 and a current ratio of 1.43. The stock’s 50-day simple moving average is $13.59 and its 200 day simple moving average is $22.01.

Hedge Funds Weigh In On Bionano Genomics

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Carret Asset Management LLC grew its stake in shares of Bionano Genomics by 89.0% during the 3rd quarter. Carret Asset Management LLC now owns 85,055 shares of the company’s stock worth $39,000 after purchasing an additional 40,055 shares during the period. GSA Capital Partners LLP acquired a new position in shares of Bionano Genomics during the 3rd quarter worth $46,000. Finally, Geode Capital Management LLC grew its stake in shares of Bionano Genomics by 47.3% during the 3rd quarter. Geode Capital Management LLC now owns 882,854 shares of the company’s stock worth $401,000 after purchasing an additional 283,639 shares during the period. 11.35% of the stock is owned by institutional investors and hedge funds.

About Bionano Genomics

(Get Free Report)

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.

Read More

Receive News & Ratings for Bionano Genomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bionano Genomics and related companies with MarketBeat.com's FREE daily email newsletter.